0

Journal Articles

in Cardiovascular Disease Prevention
 81-100 of 104 Articles
Medical News and Perspectives |  January 04, 2006
Aspirin, “Super Aspirin” Use in Women for Cardioprevention Probed
JAMA. 2006;295(1):20-21. doi:10.1001/jama.295.1.20.
Original Contribution |  April 20, 2005 FREE
Secular Trends in Cardiovascular Disease Risk Factors According to Body Mass Index in US Adults
Edward W. Gregg, PhD; Yiling J. Cheng, MD, PhD; Betsy L. Cadwell, MSPH; et al.
JAMA. 2005;293(15):1868-1874. doi:10.1001/jama.293.15.1868.
Editorial |  April 06, 2005
Cardiovascular Risk Stratification in Older Patients:  Role of Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels
Martin Schillinger, MD
JAMA. 2005;293(13):1667-1669. doi:10.1001/jama.293.13.1667.
Medical News and Perspectives |  April 06, 2005
FDA Panel: Keep COX-2 Drugs on Market
JAMA. 2005;293(13):1571-1583. doi:10.1001/jama.293.13.1571.
Original Contribution |  April 06, 2005 FREE
Effects of Exercise and Stress Management Training on Markers of Cardiovascular Risk in Patients With Ischemic Heart Disease:  A Randomized Controlled Trial
James A. Blumenthal, PhD; Andrew Sherwood, PhD; Michael A. Babyak, PhD; et al.
JAMA. 2005;293(13):1626-1634. doi:10.1001/jama.293.13.1626.
Original Contribution |  January 05, 2005 FREE
Comparison of the Atkins, Ornish, Weight Watchers, and Zone Diets for Weight Loss and Heart Disease Risk Reduction:  A Randomized Trial
Michael L. Dansinger, MD; Joi Augustin Gleason, MS, RD; John L. Griffith, PhD; et al.
JAMA. 2005;293(1):43-53. doi:10.1001/jama.293.1.43.
Medical News and Perspectives |  October 27, 2004
Jeremiah Stamler, MD: Researcher, Leader in Cardiovascular Disease Prevention
JAMA. 2004;292(16):1941-1945. doi:10.1001/jama.292.16.1941.
Brief Report |  October 06, 2004 FREE
Favorable Cardiovascular Risk Profile in Young Women and Long-term Risk of Cardiovascular and All-Cause Mortality
Martha L. Daviglus, MD, PhD; Jeremiah Stamler, MD; Amber Pirzada, MD; et al.
JAMA. 2004;292(13):1588-1592. doi:10.1001/jama.292.13.1588.
Original Contribution |  June 02, 2004 FREE
Predictive Value for the Chinese Population of the Framingham CHD Risk Assessment Tool Compared With the Chinese Multi-provincial Cohort Study
Jing Liu, MD; Yuling Hong, MD, PhD; Ralph B. D'Agostino, Sr, PhD; et al.
JAMA. 2004;291(21):2591-2599. doi:10.1001/jama.291.21.2591.
Original Contribution |  December 17, 2003 FREE
Cardiorespiratory Fitness in Young Adulthood and the Development of Cardiovascular Disease Risk Factors
Mercedes R. Carnethon, PhD; Samuel S. Gidding, MD; Rodrigo Nehgme, MD; et al.
JAMA. 2003;290(23):3092-3100. doi:10.1001/jama.290.23.3092.
Original Contribution |  November 05, 2003 FREE
Cardiovascular Risk Factors in Childhood and Carotid Artery Intima-Media Thickness in Adulthood:  The Cardiovascular Risk in Young Finns Study
Olli T. Raitakari, MD, PhD; Markus Juonala, MD; Mika Kähönen, MD, PhD; et al.
JAMA. 2003;290(17):2277-2283. doi:10.1001/jama.290.17.2277.
Original Contribution |  November 05, 2003 FREE
Childhood Cardiovascular Risk Factors and Carotid Vascular Changes in Adulthood:  The Bogalusa Heart Study
Shengxu Li, MD, MPH; Wei Chen, MD, PhD; Sathanur R. Srinivasan, PhD; et al.
JAMA. 2003;290(17):2271-2276. doi:10.1001/jama.290.17.2271.
Editorial |  October 22, 2003
Psychosocial Risk Factors for Cardiovascular Disease:  More Than One Culprit at Work
Redford B. Williams, MD; John C. Barefoot, PhD; Neil Schneiderman, PhD
JAMA. 2003;290(16):2190-2192. doi:10.1001/jama.290.16.2190.
Editorial |  August 20, 2003
Major Risk Factors for Cardiovascular Disease:  Debunking the "Only 50%" Myth
John G. Canto, MD, MSPH; Ami E. Iskandrian, MD
JAMA. 2003;290(7):947-949. doi:10.1001/jama.290.7.947.
Editorial |  June 18, 2003
Depression—A Cardiac Risk Factor in Search of a Treatment
Nancy Frasure-Smith, PhD; François Lespérance, MD
JAMA. 2003;289(23):3171-3173. doi:10.1001/jama.289.23.3171.
Original Contribution |  May 07, 2003 FREE
Impact of Electron Beam Tomography, With or Without Case Management, on Motivation, Behavioral Change, and Cardiovascular Risk Profile:  A Randomized Controlled Trial
Patrick G. O'Malley, MD, MPH; Irwin M. Feuerstein, MD; Allen J. Taylor, MD
JAMA. 2003;289(17):2215-2223. doi:10.1001/jama.289.17.2215.
Medical News and Perspectives |  February 05, 2003
FDA Orders Estrogen Safety Warnings
JAMA. 2003;289(5):537-538. doi:10.1001/jama.289.5.537.
Original Contribution |  September 20, 2000 FREE
Periodontal Disease and Coronary Heart Disease Risk
Philippe P. Hujoel, PhD; Mark Drangsholt, DDS, MPH; Charles Spiekerman, PhD; et al.
JAMA. 2000;284(11):1406-1410. doi:10.1001/jama.284.11.1406.
From the Centers for Disease Control and Prevention |  July 05, 2000 FREE
Heat-Related Illnesses, Deaths, and Risk Factors—Cincinnati and Dayton, Ohio, 1999, and United States, 1979-1997
JAMA. 2000;284(1):34-35. doi:10.1001/jama.284.1.34.
Controversies |  August 25, 1999
Surrogate End Points, Health Outcomes, and the Drug-Approval Process for the Treatment of Risk Factors for Cardiovascular Disease
Bruce M. Psaty, MD, PhD; Noel S. Weiss, MD, DrPH; Curt D. Furberg, MD, PhD; et al.
JAMA. 1999;282(8):786-790. doi:10.1001/jama.282.8.786.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
RESEARCH LETTER  |  June 17, 2013
ω-3 Fatty Acid Supplements for Secondary Prevention of Cardiovascular Disease: From “No Proof of Effectiveness” to “Proof of No Effectiveness”
Andrea Messori, PharmD; Valeria Fadda, PharmD; Dario Maratea, PharmD; et al.
JAMA Internal Medicine
Editor's Correspondence  |  June 10, 2013
Noncommunicable Diseases in Developing Countries: Focus on Research Capacity Building
Ayodele Odutayo, BHSc; Naheed Hirji, BASc
JAMA Internal Medicine
Research Letters  |  May 13, 2013
Rapid Assessment of Cardiovascular Risk Among Users of Smoking Cessation Drugs Within the US Food and Drug Administration's Mini-Sentinel Program
Sengwee Toh, ScD; Meghan A. Baker, MD, ScD; Jeffrey S. Brown, PhD; et al.
JAMA Internal Medicine
Original Investigation  |  February 4, 2013
Dietary and Supplemental Calcium Intake and Cardiovascular Disease Mortality:  The National Institutes of Health–AARP Diet and Health Study
Qian Xiao, PhD; Rachel A. Murphy, PhD; Denise K. Houston, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems